Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lin Li, Yuwei Zhang, Yudan Luo, Xianghui Meng, Guixiang Pan, Han Zhang, Yuhong Li & Boli Zhang. (2023) The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications. Drug Design, Development and Therapy 17, pages 771-790.
Read now
Read now
Jin-Fu Peng, Oluwabukunmi Modupe Salami, Cai Lei, Dan Ni, Olive Habimana & Guang-Hui Yi. (2022) Targeted mitochondrial drugs for treatment of myocardial ischaemia-reperfusion injury. Journal of Drug Targeting 30:8, pages 833-844.
Read now
Read now
Articles from other publishers (53)
Mei Ding & Shuping Fang. (2024) Astragaloside for Improving Diabetic Vasculopathy Based on Microalbuminuria and C-Reactive Protein. Journal of Biobased Materials and Bioenergy 18:6, pages 1044-1049.
Crossref
Crossref
Jinhui Wang, Junbo Zou, Yajun Shi, Nan Zeng, Dongyan Guo, He Wang, Chongbo Zhao, Fei Luan, Xiaofei Zhang & Jing Sun. (2024) Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management. Phytomedicine 128, pages 155472.
Crossref
Crossref
Caiyan Qu, Xiyue Tan, Qichao Hu, Jiao Tang, Yangyang Wang, Caiying He, ZiJia He, Bin Li, Xiaoxu Fu & Quanyu Du. (2024) A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications. Heliyon 10:5, pages e26863.
Crossref
Crossref
Yanyun Guan, Juan Zhang, Xinrui Cai, Yanan Cai, Ziqiong Song, Yuan Huang, Weibin Qian, Zhifeng Pan & Xingguo Zhang. (2024) Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway. Gene 897, pages 148040.
Crossref
Crossref
Guojian Li, Qionghui Yang, Kaikai Luo, Ankou Xu, Lijuan Hou, Zhaoxiang Li & Lingjuan Du. (2024) Astragaloside IV Protects against Shear Stress-Induced Glycocalyx Damage and Alleviates Abdominal Aortic Aneurysm by Regulating miR-17-3p/Syndecan-1. Analytical Cellular Pathology 2024, pages 1-15.
Crossref
Crossref
Ying Chen, Wen-Wen Li, Si-Ling BiHe-Meng ZhangZhenhai Sun, Yao-Yao ZuoLiang XuShou-Qiang Chen. (2024) Visualizing research trends and identifying hotspots of herbal components for treating cardiovascular diseases: A bibliometric analysis from 2000 to 2023. Medicine 103:6, pages e35047.
Crossref
Crossref
Wanting Qin, Shaoling Li, Ziji Cheng, Wenlong Xue, Mingyue Tian, Fangfang Mou, Haidong Guo, Shuijin Shao & Baonian Liu. (2024) Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII. Heliyon 10:3, pages e24779.
Crossref
Crossref
Zeyu Zhang, Yuwei Song, Xuan Zhang, Shuai Wang, Zhuangzhuang Jia, Lin Wang, Ci Wang, Xianliang Wang & Jingyuan Mao. (2024) Optimized new Shengmai powder ameliorates myocardial fibrosis in rats with heart failure by inhibition of the MAPK signaling pathway. Journal of Ethnopharmacology 319, pages 117210.
Crossref
Crossref
Jinyuan Pan, Lei Zhang, Dongxiao Li, Yuan Li, Mengkai Lu, Yuanlong Hu, Bowen Sun, Zhiyuan Zhang & Chao Li. (2024) Hypoxia-inducible factor-1: Regulatory mechanisms and drug therapy in myocardial infarction. European Journal of Pharmacology 963, pages 176277.
Crossref
Crossref
Johanna Alm, Benoit Fischer, Alexandra Emanuela Burger & Francesca Moretti. (2023) Development of a 3D Perfused In Vitro System to Assess Proangiogenic Properties of Compounds. Methods and Protocols 6:6, pages 119.
Crossref
Crossref
Qin Wang, Yong Jiang, Nina Wei, Jindong Li, Mei Zhang & Linwei Chen. (2023) Comparative pharmacokinetics of four bioactive components in normal and chronic heart failure rats after oral administration of Qiangxin Lishui Prescription by microdialysis combined with ultra‐high‐performance liquid chromatography. Journal of Separation Science 46:24.
Crossref
Crossref
Guoqing Liu, Liqiang Tan, Xiaona Zhao, Minghui Wang, Zejin Zhang, Jing Zhang, Honggang Gao, Meifang Liu & Wei Qin. (2023) Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine. Frontiers in Pharmacology 14.
Crossref
Crossref
Guo-Ying Chen, Ling-Xiao Chen, Jin Gao, Chengyu Chen, Jianli Guan, Zhiming Cao, Yuanjia Hu & Feng-Qing Yang. (2023) A Novel Molecularly Imprinted Sensor Based on CuO Nanoparticles with Peroxidase-like Activity for the Selective Determination of Astragaloside-IV. Biosensors 13:11, pages 959.
Crossref
Crossref
Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo & Ya Li. (2023) Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. Scientific Reports 13:1.
Crossref
Crossref
Jie Xi, Yan Ma, Dongmei Liu & Rong Li. (2023) Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Zhanhong Ren, Zixuan Zhang, Li Ling, Xiufen Liu & Xin Wang. (2023) Drugs for treating myocardial fibrosis. Frontiers in Pharmacology 14.
Crossref
Crossref
Jianwei Ren, Yuetian Ding, Shangze Li & Ming Lei. (2023) Predicting the anti-inflammatory mechanism of Radix Astragali using network pharmacology and molecular docking. Medicine 102:35, pages e34945.
Crossref
Crossref
Yanqin Yu, Jinqi Hao, Lu Wang, Xiaojiao Zheng, Caixia Xie, Hailiang Liu, Jiao Wu, Shu Qiao & Jihai Shi. (2023) Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway. Pathology - Research and Practice 249, pages 154766.
Crossref
Crossref
Meilian Chen & Qiaomin Wu. (2023) Roles and mechanisms of natural drugs on sinus node dysfunction. Biomedicine & Pharmacotherapy 164, pages 114777.
Crossref
Crossref
Hong Huang, Junyao Xu, Siqi Zhang, Jing Zhao, Shun Liu, Lei Tian, Haidan Wang, Zhirong Geng & Shihai Yan. (2023) A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Shen-Kui-Tong-Mai granules on a rat model with chronic heart failure. Journal of Pharmacy and Pharmacology 75:6, pages 764-783.
Crossref
Crossref
Ling Shen, Yuancheng Li, Guiying Hu, Xinli Song, Xiaoshuang Wang, Xiaoqi Li & Xiaoyuan Xu. (2023) Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling. Functional & Integrative Genomics 23:2.
Crossref
Crossref
Chunkun Yang, Qingquan Pan, Kui Ji, Zhuang Tian, Hongyuan Zhou, Shuanghong Li, Chuanchao Luo & Jun Li. (2023) Review on the protective mechanism of astragaloside IV against cardiovascular diseases. Frontiers in Pharmacology 14.
Crossref
Crossref
Qikai Niu, Hongtao Li, Lin Tong, Sihong Liu, Wenjing Zong, Siqi Zhang, SiWei Tian, Jingai Wang, Jun Liu, Bing Li, Zhong Wang & Huamin Zhang. (2023) TCMFP: a novel herbal formula prediction method based on network target’s score integrated with semi-supervised learning genetic algorithms. Briefings in Bioinformatics.
Crossref
Crossref
Linwei Chen, Nina Wei, Yong Jiang, Chengye Yuan, Luwei Xu, Jindong Li, Min Kong, Yan Chen & Qin Wang. (2023) Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure rats by microdialysis combined with UPLC-MS/MS. Journal of Ethnopharmacology 303, pages 116035.
Crossref
Crossref
Decai Chen, Yan Du, Shouwan Ye & Jinsong Yu. (2022)
Astragaloside
IV
protects against oxidized low‐density lipoprotein‐induced injury in human umbilical vein endothelial cells via the histone deacetylase 9 (
HDAC9)
/
NF‐κB
axis
. Environmental Toxicology 38:3, pages 534-544.
Crossref
Crossref
Jin-Fu Peng, Oluwabukunmi Modupe Salami, Olive Habimana, Yu-Xin Xie, Hui Yao & Guang-Hui Yi. (2022) Targeted Mitochondrial Drugs for Treatment of Ischemia-Reperfusion
Injury. Current Drug Targets 23:16, pages 1526-1536.
Crossref
Crossref
Fengyan Shen, Yong Meng, Yuhai He, Bowan Huang, Jinxin Huang & Lu Wang. (2022) Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats. Molecular Medicine Reports 27:1.
Crossref
Crossref
Ying Yang, Meng Hong, Wen-Wen Lian & Zhi Chen. (2022) Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation. World Journal of Clinical Cases 10:28, pages 10004-10016.
Crossref
Crossref
Fengyun Zhang, Bailu Duan, Zhenxiang Zhou, Lintao Han, Ping Huang, Yan Ye, Qiong Wang, Fang Huang & Jingjing Li. (2022) Integration of metabolomics and transcriptomics to reveal anti-chronic myocardial ischemia mechanism of Gualou Xiebai decoction. Journal of Ethnopharmacology 297, pages 115530.
Crossref
Crossref
Zhimin Han, Danyang Zhao, Mengfan Han, Rongjin Zhang & Yongmei Hao. (2022) Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1α Signaling Pathway and Suppressing Oxidative Stress. Oxidative Medicine and Cellular Longevity 2022, pages 1-11.
Crossref
Crossref
Fengying Gong, Rongmei Qu, Yongchun Li, Ying Lv & Jingxing Dai. (2022) Astragalus Mongholicus: A review of its anti-fibrosis properties. Frontiers in Pharmacology 13.
Crossref
Crossref
Bo-Yie Chen, Jyh-Cheng Liou, Jia-Lain Wu, Chao-Hsiang Chen & Shih-Liang Yang. (2022) Photoreceptor and vision protective effects of astragaloside IV in mice model with light-evoked retinal damage. Biomedicine & Pharmacotherapy 153, pages 113404.
Crossref
Crossref
Xingkai Liu, Qian Chen, Xuming Ji, Wanchen Yu, Tong Wang, Juanjuan Han, Shumu Li, Jianan Liu, Fangang Zeng, Yao Zhao, Yanyan Zhang, Qun Luo, Shijun Wang & Fuyi Wang. (2022) Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor. Frontiers in Pharmacology 13.
Crossref
Crossref
Huijun Li, Jialin Xu, Yanan Zhang, Lei Hong, Zhijian He, Zhiheng Zeng & Li Zhang. (2022) Astragaloside IV alleviates senescence of vascular smooth muscle cells through activating Parkin-mediated mitophagy. Human Cell 35:6, pages 1684-1696.
Crossref
Crossref
Pei-Rong Qu, Zhi-Lin Jiang, Ping-Ping Song, Lan-Chun Liu, Mi Xiang & Jie Wang. (2022) Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance. Pharmacological Research 182, pages 106352.
Crossref
Crossref
Yasmin M. Ahmed, Raha Orfali, Doaa S. Hamad, Mostafa E. Rateb & Hanan O. Farouk. (2022) Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation. Pharmaceutics 14:8, pages 1536.
Crossref
Crossref
I.-Ling Hung, Chia-Jung Chung, Wen-Long Hu, Yen-Nung Liao, Chung-Y. Hsu, Jen-Huai Chiang & Yu-Chiang Hung. (2022) Chinese Herbal Medicine as an Adjunctive Therapy Improves the Survival Rate of Patients with Ischemic Heart Disease: A Nationwide Population-Based Cohort Study. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-10.
Crossref
Crossref
Yi Tan, Meng Sam Cheong & Wai San Cheang. (2022) Roles of Reactive Oxygen Species in Vascular Complications of Diabetes: Therapeutic Properties of Medicinal Plants and Food. Oxygen 2:3, pages 246-268.
Crossref
Crossref
Cheng Li, Hao Zhu, Shaoze Zhang, Fang Meng, San Li, Guang Li, Jun Zha, Shangjie Wu, Liming Zhu & Aiguo Dai. (2022) Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response. Phytomedicine 102, pages 154171.
Crossref
Crossref
Lung-Shuo Wang, Pei-Tzu Yen, Shih-Feng Weng, Jong-Hau Hsu & Jwu-Lai Yeh. (2022) Clinical Patterns of Traditional Chinese Medicine for Ischemic Heart Disease Treatment: A Population-Based Cohort Study. Medicina 58:7, pages 879.
Crossref
Crossref
Wenlong Hao, Minghao Li, Qingmin Cai, Shiying Wu, Xiangyao Li, Quanyu He & Yongbin Hu. (2022) Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Frontiers in Physiology 13.
Crossref
Crossref
Xu-Qin Du, Li-Peng Shi, Zhi-Wei Chen, Jin-Yuan Hu, Biao Zuo, Yu Xiong & Wen-Fu Cao. (2022) Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Zhaodi Han, Linling Guo, Xinyue Yu, Huimin Guo, Xiaoying Deng, Jiayu Yu, Xueyang Deng, Fengguo Xu, Zunjian Zhang & Yin Huang. (2022) Network-driven targeted analysis reveals that Astragali Radix alleviates doxorubicin-induced cardiotoxicity by maintaining fatty acid homeostasis. Journal of Ethnopharmacology 287, pages 114967.
Crossref
Crossref
Guozuo Wang, Xiaomei Zeng, Kailin Yang, Shengqiang Gong, Anqi Ge, Wenlong Liu, Qi He, Wenhao Zhang & Jinwen Ge. (2022) Uncovering the Neuroprotective Effect of Hedysarum multijugum Maxim-Chuanxiong Rhizoma Compound on Cerebral Infarction through Quantitative Proteomics. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-13.
Crossref
Crossref
Yifan Zhang, Min Du, Jiarou Wang & Ping Liu. (2022) Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhongbo Shi, Junhao Jiang, Dezhang Zhao, Baogang Xie, Yan Li & Chao Yu. (2022) Effects of Astragaloside IV on the Pharmacokinetics of Metoprolol in Rats and its
Mechanism. Current Drug Metabolism 23:2, pages 131-136.
Crossref
Crossref
He-Rong Cui, Ji-Yuan Zhang, Xue-Hao Cheng, Jia-Xin Zheng, Qi Zhang, Rui Zheng, Liang-Zhen You, Dong-Ran Han & Hong-Cai Shang. (2022) Immunometabolism at the service of traditional Chinese medicine. Pharmacological Research 176, pages 106081.
Crossref
Crossref
Liang Wang, Hui Shi, Chun-chun Zhao, Jing-ya Li, Jian-fei Peng, An-lu Shen, Peng Zhou & Hui-min Bian. (2022) Astragaloside IV protects diabetic cardiomyopathy against inflammation and apoptosis via regulating TLR4/MyD88/NF-κB signaling pathway. Journal of Functional Foods 88, pages 104905.
Crossref
Crossref
Cuiyun Huang, Shi Qiu, Xiangcheng Fan, Guangyang Jiao, Xun Zhou, Mei Sun, Nan Weng, Shouhong Gao, Xia Tao, Feng Zhang & Wansheng Chen. (2021) Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats. Biomedicine & Pharmacotherapy 144, pages 112354.
Crossref
Crossref
Peipei Meng, Rui Yang, Fenjun Jiang, Jianbo Guo, Xinyu Lu, Tao Yang & Qingyong He. (2021) Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress. Oxidative Medicine and Cellular Longevity 2021, pages 1-8.
Crossref
Crossref
Ming Zhang, You‐wen Wang, Yuan‐zhang Zhu & Xiao‐ling Gu. (2021) Discovery of quality control ingredients in burdock root by combining anti‐tumor effects and UHPLC–QqQ–MS/MS. Biomedical Chromatography 35:11.
Crossref
Crossref
Yu-Xin Guo, Yuan Zhang, Yu-Han Gao, Si-Ying Deng, Li-Mei Wang, Cui-Qin Li & Xing Li. (2021) Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy. Frontiers in Pharmacology 12.
Crossref
Crossref
Mariam Abady, Ji-Seon Jeong & Ha-Jeong Kwon. (2022) Development and Validation of an Analytical Method Using Liquid Chromatography-Tandem Mass Spectrometry for the Therapeutic Drug Monitoring of Seven Cardiovascular Drugs in Clinical Usage. SSRN Electronic Journal.
Crossref
Crossref